---
$id: https://graph.org.ai/products/commodity/51333407
$type: Product
source: UNSPSC
code: "51333407"
title: "Mafoprazine"
class: "51333400"
classTitle: "Antipsychotic piperazines"
family: "51330000"
familyTitle: "Antipsychotics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Mafoprazine

**UNSPSC Code**: 51333407
**Class**: [Antipsychotic piperazines](Antipsychotic piperazines.mdx)
**Family**: [Antipsychotics](../Antipsychotics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antipsychotic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D7UUO54C6N. European Medicines Agency schedules Mafoprazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08634MIG. Mafoprazine generally arises in the molecular formula C22H28FN3O3. The term MAFOPRAZINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, no. 4, 1987, list 27.) MAFOPRAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule mafoprazine under HS 29335995 and SITC 51576. As of Q4 2014, MAFOPRAZINE remains the US FDA Preferred Term for this commodity. Mafoprazine bears US NLM identifiers UMLS ID C0065505 and NCI Concept Code C66047. SMILES: FC1C(N2CCN(CC2)CCCOC2C(OC)CC(NC(=O)C)CC2)CCCC1.

